The costs of developing treatments for Alzheimer's disease: A retrospective exploration.

Cummings, Jeffrey L; Goldman, Dana P; Simmons-Stern, Nicholas R; Ponton, Eric

Cummings, Jeffrey L; Goldman, Dana P; Simmons-Stern, Nicholas R; Ponton, Eric.

Cummings JL; Chambers-Grundy Center for Transformative Neuroscience, Department of Brain Health, School of Integrated Health Sciences, University of Nevada, Las Vegas, Nevada, USA.
Goldman DP; University of Southern California, Los Angeles, California, USA.
Simmons-Stern NR; Biogen, Cambridge, Massachusetts, USA.
Ponton E; Biogen, Cambridge, Massachusetts, USA.

Alzheimers Dement ; 18(3): 469-477, 2022 03.

Article en En | MEDLINE | ID: mdl-34581499

Asunto(s)

Enfermedad de Alzheimer; Enfermedad de Alzheimer/tratamiento farmacológico; Desarrollo de Medicamentos; Gastos en Salud; Humanos; Estudios Retrospectivos

Palabras clave

Alzheimer's disease; clinical trials; funding; industry; research and development

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Alzheimer Tipo de estudio: Health_economic_evaluation / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google